Andrew Dudum | |
|---|---|
| Alma mater | University of Pennsylvania (Wharton School) |
| Occupation | Entrepreneur |
| Years active | 2010–present |
| Known for | Founder and CEO of Hims & Hers Health |
| Title | CEO, Hims & Hers Health |
Andrew Dudum is a Palestinian-American entrepreneur who is the founder and CEO of telehealth startup Hims & Hers Health, Inc.
Dudum was born and raised in San Francisco, California. He is an American of Palestinian heritage. He trained as a classical cellist and performed live across the United States and Europe, at hundreds of concerts and weddings, including at Carnegie Hall. [1] He attended the Wharton School of the University of Pennsylvania, where he studied Management and Economics. Dudum did not finish his degree and is therefore a college dropout. [2]
While in college, Dudum co-founded LendforPeace, a nonprofit microlending site for Middle Eastern entrepreneurs. He later worked at TokBox, a video-chat startup that was eventually acquired. [1] The acquisition of TokBox freed Dudum up to pursue his goal to build a startup. In 2013, Dudum co-founded Atomic Labs, a San Francisco-based startup studio backed by investors such as Peter Thiel and Marc Andreessen. Atomic launched companies including Bungalow, Homebound, TalkIQ, and Terminal. [2] [3] In 2016, Dudum founded Hims, a direct-to-consumer telehealth startup, still as part of Atomic. He has served as CEO since its inception. [2] The company expanded into women's health under the brand Hims & Hers, offering online consultations, prescriptions, and over-the-counter products. [4] [ circular reference ] Hims raised over US$100 million in funding and became a “unicorn” in 2019. In 2020, Hims went public via a SPAC at a $1.6 billion valuation, debuting on the New York Stock Exchange in January 2021 under the ticker NYSE : HIMS. [5] In 2024, Hims & Hers expanded into GLP-1 weight loss medicine and generated annual revenues of $1.48 billion. [6] [7] [8] Andrew Dudum has a net worth of approximately $1 billion. [9] [10]
In 2024, Dudum drew both praise and some criticism for a social media post in which he encouraged companies to hire student protesters involved in anti-Israel demonstrations. He later clarified his statement as support for peaceful protest and free speech. [1] [11]
In 2025, his San Francisco donut shop, George's Donuts & Merriment, drew local backlash after a $1 million Hims & Hers donation to President Donald Trump's inaugural committee became public. [12]
In mid-2025, Hims & Hers Health faced increased scrutiny after its partnership with Novo Nordisk ended, with both companies citing differing views on compounded GLP-1 weight-loss drugs. Reuters and Bloomberg reported that despite the termination, Hims continued its expansion and reaffirmed annual guidance. [13] [14]